Work

Survival in Patients with Glioblastoma Receiving Valganciclovir

Year: 2013
Type: article
Abstract: A retrospective analysis of selected patients with glioblastoma who received treatment for cytomegalovirus with their anticancer treatment showed surprisingly good 2-year survival. A randomized trial is needed.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2105350040
FWCI: 14.78
Cites: 5
Cited by: 195
Related to: 10